NCT01476982

Brief Summary

The primary objective of this feasibility study is to determine whether it is possible to conduct a study of the ClearView scan among patients under evaluation for acute cardiovascular events, as well as give insight into the performance of the ClearView scoring algorithm with respect to this patient population. The EPIC™ scan is a bio-electrographic tool that may assist the health care provider in rapid assessment of the systemic origin of the patient's presenting symptom(s). The EPIC ClearView is a potentially valuable resource that may benefit an emergency department (ED) by offering expedited "chest pain" etiologic differentiation capabilities. The subsequent results have the potential to include more rapid "chest pain" patient diagnosis and appropriate disposition of non-cardiac chest pain (rule out MI); optimized precious resource expenditure (nursing, physician, inpatient or observation bed, etc.); lower costs to facility, patient and insurance company; and greater patient satisfaction rates due to decreased ED wait time.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 28, 2011

Completed
25 days until next milestone

First Posted

Study publicly available on registry

November 22, 2011

Completed
5 months until next milestone

Study Start

First participant enrolled

May 1, 2012

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2013

Completed
Last Updated

March 20, 2013

Status Verified

March 1, 2013

Enrollment Period

1.1 years

First QC Date

October 28, 2011

Last Update Submit

March 18, 2013

Conditions

Outcome Measures

Primary Outcomes (1)

  • Agreement of ClearView scan versus Active (Presenting) Diagnosis

    Statistical agreement will be assessed between the 0-25 ClearView Response Scale and the presenting diagnosis/diagnoses for the Emergency Department admission recorded within the medical record, on a per-subject basis.

    At time of study scan (Single study visit only, with no follow-up. The study endpoint will be reported for day 0, the day of the study visit.)

Study Arms (1)

Emergency Department Patients

Patients presenting to the Emergency Department complaining of chest pain.

Device: ClearView Scan

Interventions

Assessment with ClearView device

Emergency Department Patients

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Men and women, ages 18-85, presenting to the Emergency Department with chest pain.

You may qualify if:

  • Sex: Male or Female
  • Age range: 18 to 85
  • Chief complaint upon admission to the ED: chest pain
  • The patient or legal representative is able to understand and provide signed consent for the procedure.
  • Every effort will be given to balance subjects by gender, age, and race.

You may not qualify if:

  • Patients \< 18 years in age or \> 85 years in age.
  • Inability or unwillingness to provide informed consent.
  • Patients with pacemakers or another electrical device, such as an automatic internal cardiac defibrillator, implanted somewhere in their body.
  • Patients connected to an electrical device that cannot be removed (i.e. monitor).
  • Pregnant women.
  • Patients currently undergoing therapy for cancer of any kind.
  • Patients missing all or part of any of their fingers.
  • Patients with hand tremors or involuntary oscillations ("shaking") of the hands that prevent clear imaging.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Scottsdale Healthcare Osborn Campus

Scottsdale, Arizona, 85251, United States

Location

Scottsdale Healthcare Shea Campus

Scottsdale, Arizona, 85260, United States

Location

Related Links

Study Officials

  • Krishnaswami Vijayaraghavan, MD

    Scottsdale Healthcare

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 28, 2011

First Posted

November 22, 2011

Study Start

May 1, 2012

Primary Completion

June 1, 2013

Last Updated

March 20, 2013

Record last verified: 2013-03

Locations